Clinical Operations, • 9/19/25 Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Previous Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Next Optimizing CRO and Vendor Selection - Examples from the Field You Might Also Like Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials Reducing Patient Burden in Rare Disease Trials How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Optimizing CRO and Vendor Selection - Examples from the Field How To Prevent Failure in Rare Disease Trials?
Clinical Operations, • 9/19/25 Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Previous Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Next Optimizing CRO and Vendor Selection - Examples from the Field You Might Also Like Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials Reducing Patient Burden in Rare Disease Trials How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Optimizing CRO and Vendor Selection - Examples from the Field How To Prevent Failure in Rare Disease Trials?
